11.23
-0.6(-5.07%)
Currency In USD
| Previous Close | 11.83 |
| Open | 11.8 |
| Day High | 12.03 |
| Day Low | 11.11 |
| 52-Week High | 18.98 |
| 52-Week Low | 5.45 |
| Volume | 330,179 |
| Average Volume | 289,758 |
| Market Cap | 368.33M |
| PE | -13.7 |
| EPS | -0.82 |
| Moving Average 50 Days | 12.87 |
| Moving Average 200 Days | 10.73 |
| Change | -0.6 |
If you invested $1000 in NeuroPace, Inc. (NPCE) since IPO date, it would be worth $449.92 as of June 13, 2025 at a share price of $11.23. Whereas If you bought $1000 worth of NeuroPace, Inc. (NPCE) shares 3 years ago, it would be worth $1,782.54 as of June 13, 2025 at a share price of $11.23.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NeuroPace Secures Up to $75 Million in Debt Financing
GlobeNewswire Inc.
Jun 04, 2025 8:09 PM GMT
MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has entered into a new $75 million
NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study
GlobeNewswire Inc.
May 27, 2025 12:00 PM GMT
-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study met the 12-week post-implant primary safety endpoint
NeuroPace Provides Update on Tariff Status
GlobeNewswire Inc.
Apr 14, 2025 8:05 PM GMT
-- Minimal expected impact to operations and financial results -- -- Company to report first quarter 2025 financial results on May 13, 2025 -- MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical devic